Novartis Receives EU Approval for Drug that Treats Rare Hormonal Disorder

November 24, 2014 2:32 PM

3 0

Novartis International announced on Monday that it has received approval from the European Commission for its drug called Signifor to treat a rare hormonal disorder called acromegaly.

Novartis International announced on Monday that it has received approval from the European Commission for its drug called Signifor to treat a rare hormonal disorder called acromegaly.

Read more

To category page

Loading...